© FUJIFILM Corporation

Fujifilm’s New AI-based Technology for Lung Nodule Detection Now Approved for Use in Japan


TOKYO, May 19, 2020 —FUJIFILM Corporation (President: Kenji Sukeno) is pleased to announce the company’s Artificial Intelligence (AI)-based lung nodule detection technology— an algorithm developed to assist diagnostic imaging by automatically detecting lung nodules in chest computed tomography (CT) scans— has been cleared by the Pharmaceutical and Medical Device Act*3. The algorithm will be released in Japan on June 1, 2020 through FUJIFILM Medical Co., Ltd. (President: Akio Niinobe).

More Details